Clare Market Investments LLC Abbott Laboratories Transaction History

Clare Market Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Feb 20, 2025	SELL	$102.07 - $123.37 $268,750 - $324,833	-2,633 Closed	0 $0
Q1 2022 Feb 20, 2025	BUY	$114.02 - $139.04 $23,602 - $28,781	207 Added 8.53%	2,633 $312 Million
Q4 2021 Feb 20, 2025	SELL	$115.53 - $141.46 $11,090 - $13,580	-96 Reduced 3.81%	2,426 $341 Million
Q3 2021 Feb 20, 2025	BUY	$116.66 - $129.06 $29,631 - $32,781	254 Added 11.2%	2,522 $297,000
Q2 2021 Feb 20, 2025	BUY	$105.79 - $124.53 $634 - $747	6 Added 0.27%	2,268 $263 Million
Q1 2021 Feb 20, 2025	BUY	$108.84 - $128.23 $435 - $512	4 Added 0.18%	2,262 $271 Million
Q4 2020 Feb 20, 2025	BUY	$105.0 - $114.42 $237,090 - $258,360	2,258 New	2,258 $247 Million

3,361

1.36B

10.6M

8.73M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Clare Market Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Clare Market Investments LLC with notifications on news.